VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, cardiometabolic disease and exposomics. Contact us to discuss how you can add breath research to your own research.
There are 13 results matching your search criteriaClear all filters
Could breath monitoring allow early intervention for COPD exacerbations?
Respiratory Disease, COPD, Inflammatory Disease
Detecting VOCs for exercise induced bronchoconstriction in asthmatic children
Respiratory Disease, Asthma, Pediatrics
Distinguishing COPD from lung cancer in a large cohort study
Respiratory Disease, Asthma, COPD
Reviewing breath biomarkers for inflammatory respiratory diseases
Respiratory Disease, Asthma, Lung Cancer, COPD, Inflammatory Disease
Breath analysis for detecting cystic fibrosis and Pseudomonas exacerbations
Identifying Asthma and assessing control using Breath Biopsy
Respiratory Disease, Asthma, COPD, Inflammatory Disease
Identifying pathogens on breath via the lung microbiome
Respiratory Disease, Infectious Disease
Stratifying acute cardiorespiratory breathlessness with breath metabolites
Cardiovascular & metabolic disease (CVMD), Respiratory Disease, Asthma, COPD, Inflammatory Disease